Literature DB >> 21890460

MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma.

Jun Lin1, Shenglin Huang, Shunquan Wu, Jie Ding, Yingjun Zhao, Linhui Liang, Qi Tian, Ruopeng Zha, Rong Zhan, Xianghuo He.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNA molecules that are often located in genomic breakpoint regions and can act as oncogenes or tumor suppressor genes in human cancer. Our previous study showed that microRNA-423 (miR-423), which localized to the frequently amplified region of chromosome 17q11, was upregulated in hepatocellular carcinoma (HCC). However, the potential functions and exact mechanistic roles of miR-423 in hepatic carcinogenesis remain unknown. Here, we demonstrated that miR-423 significantly promotes cell growth and cell cycle progression at the G(1)/S transition in HCC cells. In particular, we found that miR-423-3p contributes to these effects, whereas miR-423-5p does not. Further studies revealed that p21Cip1/Waf1 is a downstream target of miR-423 in HCC cells, as miR-423 bound directly to its 3' untranslated region and reduced both the messenger RNA and protein levels of p21Cip1/Waf1. Moreover, enforced expression of p21Cip1/Waf1 abrogated miR-423-induced effects on HCC cell proliferation and cell cycle progression. These findings indicate that miR-423 exerts growth-promoting effects in hepatic carcinogenesis through the suppression of tumor suppressor p21Cip1/Waf1 expression. The results of this study define miR-423 as a new oncogenic miRNA in HCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21890460     DOI: 10.1093/carcin/bgr199

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  50 in total

1.  Genetic analysis and preliminary function study of miR-423 in breast cancer.

Authors:  Huanhuan Zhao; Ang Gao; Zhiqian Zhang; Ruoyu Tian; Ang Luo; Mei Li; Dan Zhao; Liya Fu; Li Fu; Jin-Tang Dong; Zhengmao Zhu
Journal:  Tumour Biol       Date:  2015-02-08

Review 2.  The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects.

Authors:  Motoyuki Otsuka; Takahiro Kishikawa; Takeshi Yoshikawa; Motoko Ohno; Akemi Takata; Chikako Shibata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2013-11-21       Impact factor: 7.527

3.  Identification of miR-423 and miR-499 polymorphisms on affecting the risk of hepatocellular carcinoma in a large-scale population.

Authors:  Yanyun Ma; Rui Wang; Jun Zhang; Wenshuai Li; Chunfang Gao; Jie Liu; Jiucun Wang
Journal:  Genet Test Mol Biomarkers       Date:  2014-05-22

4.  Effect of taurine on the proliferation and apoptosis of human hepatocellular carcinoma HepG2 cells.

Authors:  Shuo Tu; Xiali Zhang; Daya Luo; Zhuoqi Liu; Xiaohong Yang; Huifang Wan; Lehan Yu; Hua Li; Fusheng Wan
Journal:  Exp Ther Med       Date:  2015-05-07       Impact factor: 2.447

5.  MicroRNAs As Biomarkers For Clinical Features Of Lung Cancer.

Authors:  Roland Hubaux; Daiana D Becker-Santos; Katey S S Enfield; Stephen Lam; Wan L Lam; Victor D Martinez
Journal:  Metabolomics (Los Angel)       Date:  2012-03-21

6.  microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma.

Authors:  Guofang Guan; Dejun Zhang; Ying Zheng; Lianji Wen; Duojiao Yu; Yanqing Lu; Yan Zhao
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

7.  Overexpression of miR-1260b in Non-small Cell Lung Cancer is Associated with Lymph Node Metastasis.

Authors:  Limin Xu; Liqin Li; Jing Li; Hongwei Li; Qibin Shen; Jinliang Ping; Zhihong Ma; Jing Zhong; Licheng Dai
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

8.  miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3).

Authors:  Ling-yun Zhang; Min Liu; Xin Li; Hua Tang
Journal:  J Biol Chem       Date:  2012-12-04       Impact factor: 5.157

9.  Detection of Drug-Induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c, and -423.

Authors:  Mira Pavkovic; Cassianne Robinson-Cohen; Alicia S Chua; Oana Nicoara; Mariana Cárdenas-González; Vanesa Bijol; Krithika Ramachandran; Lucy Hampson; Munir Pirmohamed; Daniel J Antoine; Gyorgy Frendl; Jonathan Himmelfarb; Sushrut S Waikar; Vishal S Vaidya
Journal:  Toxicol Sci       Date:  2016-04-27       Impact factor: 4.849

10.  Distinctive microRNA expression signatures in proton-irradiated mice.

Authors:  Shahid Yar Khan; Muhammad Akram Tariq; James Patrick Perrott; Christopher Drew Brumbaugh; Hyunsung John Kim; Muhammad Imran Shabbir; Govindarajan T Ramesh; Nader Pourmand
Journal:  Mol Cell Biochem       Date:  2013-07-02       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.